Blues plans crushed by risk adjustment freeze as Kaiser skirts nearly $1B

Kaiser Permanente
Kaiser Permanente stands to save $928 million if the risk adjustment freeze holds. (Ted Eytan/CC BY-SA 2.0)

Some of Blue Cross Blue Shield’s biggest affiliated insurers would be the hardest hit by the Trump administration’s decision to freeze more than $10 billion in risk adjustment payments.

Should those payments remain frozen, three insurers—Blue Shield of California, Health Care Services Corporation and Blue Cross Blue Shield of Florida—would miss out on more than $2 billion due this fall, according to data released (PDF) by the Centers for Medicare & Medicaid Services.

RELATED: CMS suspends $10.4B in risk adjustment payments to insurers

Conference

13th Partnering with ACOS & IDNS Summit

This two-day summit taking place on June 10–11, 2019, offers a unique opportunity to have invaluable face-to-face time with key executives from various ACOs and IDNs from the entire nation – totaling over 3.5 million patients served in 2018. Exclusively at this summit, attendees are provided with inside information and data from case studies on how to structure an ACO/IDN pitch, allowing them to gain the tools to position their organization as a “strategic partner” to ACOs and IDNs, rather than a merely a “vendor.”

Blue Shield of California is owed the most at $696 million, followed by BCBS of Florida at $686 million and HCSC, a Blues-affiliated insurer, at $640 million.

The data, which outlines risk adjustment transfers for the 2017 year, comes days after the agency announced it would freeze payments, citing a New Mexico court decision earlier this year that ruled CMS must rework its risk adjustment formula. Under the Affordable Care Act, risk adjustment was meant to prevent insurers from turning away the sickest patients.

However, several other insurers would benefit handsomely from the decision. Kaiser Permanente, which operates plans in eight states and the District of Columbia, stands to save $928 million if CMS elects not to make the payments. Molina owes $852 million and Centene, including its recent acquisition of Fidelis, owes $689 million.

Critics see the delay as another effort by the Trump administration to sabotage the individual market, and the move is expected to drive up premiums and force insurers off the marketplace. But policy experts believe CMS will ultimately make the payments this fall.

Suggested Articles

The FTC is suing Surescripts, accusing the health IT company of employing illegal restraints to maintain its monopolies over the e-prescribing market.

Group plans for small businesses may offer a lower-cost option in comparison to individual market coverage, according to a new report. 

Ohio’s attorney general is continuing his war on PBMs, this time by proposing a multi-step plan to improve transparency and lower drug costs.